Back to Trades
BeOne Medicines Ltd.
ONCCIK: 0001651308
Follow ONC
Track BeOne Medicines Ltd. insider trades on your dashboard. Email alerts with a subscription.
BeOne Medicines Ltd. (ONC) has recorded 50 insider filings from 17 unique insiders, totaling $271.1M in trading activity (net selling). Insiders have sold $212.0M while purchasing $0. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is OYLER JOHN. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$271.1M
Purchases
$0
Sales
$212.0M
Unique Insiders
17
Recent Insider Trades
50 loaded
| Jul 17 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $20.2M |
| Jul 17 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $89.4M |
| Jul 14 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $44.6M |
| Jul 14 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $18.3M |
| Jul 10 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $200.8K |
| Jun 25 | ONC BeOne Medicines Ltd. | Wu Xiaobin | President and COO | Sell | $356.9K |
| Jun 25 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $933.6K |
| Jun 25 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $295.6K |
| Jun 18 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $156.9K |
| Jun 18 | ONC BeOne Medicines Ltd. | Wu Xiaobin | President and COO | Sell | $362.0K |
| Jun 18 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $980.7K |
| Jun 18 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $310.2K |
| Jun 15 | ONC BeOne Medicines Ltd. | Sharp Shalini | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Mooney Elizabeth Fisher | Director | Other | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Sawyers Charles Lazelle | Director | Other | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | BRANDICOURT OLIVIER | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Wang Xiaodong | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Riva Alessandro | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Mooney Elizabeth Fisher | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Sawyers Charles Lazelle | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Rosenberg Aaron | Chief Financial Officer | Sell | $162.6K |
| Jun 15 | ONC BeOne Medicines Ltd. | Wu Xiaobin | President and COO | Sell | $163.5K |
| Jun 15 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $501.4K |
| Jun 15 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $110.3K |
| Jun 15 | ONC BeOne Medicines Ltd. | HOOPER ANTHONY C | Director | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | Ball Titus B. | Principal Accounting Officer | Sell | $43.5K |
| Jun 15 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $197.3K |
| Jun 15 | ONC BeOne Medicines Ltd. | Dugan Margaret | Director | Grant | $0 |
| Jun 10 | ONC BeOne Medicines Ltd. | Ball Titus B. | Principal Accounting Officer | Sell | $36.9K |
| Jun 10 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $368.2K |
| Jun 10 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $1.3M |
| Jun 10 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $235.5K |
| Jun 10 | ONC BeOne Medicines Ltd. | Wu Xiaobin | President and COO | Sell | $399.7K |
| Jun 3 | ONC BeOne Medicines Ltd. | Yi Qingqing | Director | Sell | $65.6K |
| May 27 | ONC BeOne Medicines Ltd. | Riva Alessandro | Director | Sell | $65.6K |
| May 27 | ONC BeOne Medicines Ltd. | Dugan Margaret | Director | Sell | $65.6K |
| May 27 | ONC BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP | Insider | Sell | $262.0K |
| May 27 | ONC BeOne Medicines Ltd. | Sanders Corazon (Corsee) D. | Director | Sell | $65.6K |
| Apr 10 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $103.4K |
| Mar 13 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $102.3K |
| Mar 10 | ONC BeOne Medicines Ltd. | Rosenberg Aaron | Chief Financial Officer | Grant | $0 |
| Mar 10 | ONC BeOne Medicines Ltd. | Wu Xiaobin | President and COO | Grant | $0 |
| Mar 10 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Grant | $0 |
| Mar 10 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Grant | $0 |
| Mar 10 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Grant | $0 |
| Feb 6 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $580.2K |
| Jan 9 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $220.3K |
| Dec 17 | ONC BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer, Director | Sell | $30.7M |
| Dec 12 | ONC BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | Sell | $213.6K |
50 filings+